Rigel Reports Second Quarter 2026 Financial Results
Go back to Rigel Reports Second Quarter 2026 Financial Results| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 48.11 +1.02 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.09 | 52 Week High | $4.38 | |||
| Open | $47.50 | 52 Week Low | $1.88 | |||
| Day High | $48.54 | P/E | N/A | |||
| Day Low | $47.23 | EPS | $-1.12 | |||
| Volume | 53,855 | |||||

